While RSV can become severe for any child, it poses a particularly serious threat for the youngest babies and for high-risk children.
Academic rigour, journalistic flair
Articles on Antivirals
Displaying all articles
Declaring monkeypox a national health emergency will allow the U.S. government to direct resources and funds where needed to help slow the spread of the virus.
After taking Paxlovid for COVID and appearing to recover, some people – including US President Joe Biden – continue to test positive. What’s going on?
According to a letter from Biden’s doctor, the president has a runny nose, mild fatigue and a slight cough. The letter also noted that Biden began taking an antiviral drug the morning he tested positive.
If you do get COVID and you’re eligible for antiviral treatment, you’ll want to get them quickly. That’s why being prepared is a good idea.
After testing positive for COVID, your medicine prescription will depend on the severity of your symptoms and any other health conditions you have.
Here’s who is eligible, the benefits and side effects to consider.
An infectious disease doctor discusses the use, benefits and availability of a drug to prevent severe COVID-19.
Earlier detection and treatment of COVID-19 by health care providers in pharmacies could help prevent surges in infection rates and severe illness.
Most people with COVID will recover at home without any treatment. But some people who are at risk of severe disease could benefit from new medicines to reduce the chance of the disease progressing.
Medications to treat COVID-19 are in no way a substitute for the vaccine. But under the right circumstances, some show great promise for helping patients.
Researchers around the world are using new and existing technology to develop potential treatments for those with COVID-19. Here’s what’s in development in Australia.
This treatment would work by targeting the SARS-CoV-2 virus itself and stopping it in its tracks. The evidence we have so far is promising, but it’s still very early days.
Top contributors
-
Assistant Professor of Infectious Diseases, University of Virginia
-
Director, Evidence and Methods, National COVID-19 Clinical Evidence Taskforce; Associate Professor (Research), Cochrane Australia, School of Population Health and Preventive Medicine, Monash University, Monash University
-
Monash University
-
Oliver Frank is a Friend of The Conversation.
Senior Research Fellow, Discipline of General Practice, and Specialist General Practitioner, University of Adelaide
-
Professional Research Fellow, Victoria University
-
Associate Professor of the Sydney Pharmacy School, University of Sydney
-
Professor of Immunology and Pro Vice-Chancellor, Research Partnerships, Victoria University
-
Associate Professor of Epidemiology, University of San Francisco
-
Professor of Pharmacy Practice, University of Connecticut
-
Conjoint Professor, School of Medicine and Public Health, University of Newcastle
-
Professor of general practice, Bond University
-
Pharmacist and PhD Candidate, University of Sydney
-
Research Leader in Virology and Infectious Disease, Griffith University
-
Research Officer - Immunology and Translational Research, Victoria University
-
Associate Professor of Comparative Effectiveness and Outcomes Research, University of Connecticut
